Coeptis Therapeutics
Phil Deschamps is an experienced and dedicated healthcare executive, and currently is the President and CEO of Chitogenix, formerly, Ortho Regenerative Technologies. Since his tenure at Chitogenix began in March of 2022, Deschamps’s primary mandate is to uncover expanded commercial uses for the company’s proprietary bio-polymer drug combination products.
This person is not in the org chart
This person is not in any offices
Coeptis Therapeutics
Coeptis Therapeutics focuses on the development and acquisition of pharmaceutical products.